Browsing by author "Zannino, Diana"
Sort by:
Title A-Z
-
The cost effectiveness of bevacizumab when added to capecitabine, with or without mitomycin-C, in first line treatment of metastatic colorectal cancer: results from the Australasian phase III MAX study
Carter, Hannah; Zannino, Diana; Simes, R John; Schofield, Deborah J; Howard, Kirsten; Zalcberg, John R; Price, Timothy J; Tebbutt, Niall CPublished 2015-12-14Background: Based on the clinical data, bevacizumab has been approved in Australia and globally for the treatment of advanced colorectal cancer. However, limited evidence exists for its cost-effectiveness. The purpose of ...Open AccessArticle -
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Drury, Paul L; Ting, Ru-Dee; Zannino, Diana; Ehnholm, Christian; Flack, Jeff; Whiting, Malcolm; Fassett, Robert; Ansquer, Jean-Claud; Dixon, Paul; Davis, Timothy ME; Pardy, Christopher; Colman, Peter; Keech, AnthonyPublished 2011-01-01Background We investigated effects of renal function and albuminuria on cardiovascular outcomes in 9795 low-risk patients with diabetes in the Fenofibrate Intervention and Event Lowering in Diabetes study. Methods Baseline ...Open AccessArticle -
Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
D'Emden, Michael C; Jenkins, Alicia J; Li, Liping; Zannino, Diana; Mann, Kristy P; Best, James D; Stuckey, Bronwyn GA; Park, Kris; Saltevo, Juha; Keech, Anthony CPublished 2014-08-23Aims/hypothesis In the double-blind placebo-controlled Fenofibrate Intervention and Event Lowering in Diabetes trial (n=9795), fenofibrate reduced major cardiovascular events in type 2 diabetes. Sex-related differences in ...Open AccessArticle -
Sentinel-lymph-node-based management or routine axillary clearance? Three-year outcomes of the RACS Sentinel Node Biopsy versus Axillary Clearance (SNAC) 1 trial
Wetzig, Neil; Gill, Peter Grantley; Zannino, Diana; Stockler, Martin R; Gebski, Val; Ung, Owen; Campbell, Ian; Simes, R JohnPublished 2014-10-15Purpose We sought to determine whether the benefits of sentinel-node-based management (SNBM) over routine axillary clearance (RAC) at 1 year persisted to 3 years of follow-up. Methods 1088 women with clinically node ...Open AccessArticle
Sort by:
Title A-Z